AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,988.00p
   
  • Change Today:
    -38.00p
  • 52 Week High: 12,144.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.22m
  • Volume: 1,636,659
  • Market Cap: £185,840m
  • RiskGrade: 123

Key dates

Dividend  
Latest XD Date (2nd Interim) 22-Feb-2024
Latest Pay Date (2nd Interim) 25-Mar-2024
   
Meetings  
AGM 11-Apr-2024
EGM n/a
GMs n/a
   
Announcements  
Trading announcement n/a
IMSs n/a
Drilling Report n/a
   
Results  
Final results 08-Feb-2024
Interim results 25-Jul-2024
Q1 Results 25-Apr-2024
Q2 Results 25-Jul-2024
Q3 Results 12-Nov-2024
Q4 Results 08-Feb-2024
Annual Report 20-Feb-2024
   
Year End 31-Dec-2024

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,988.00p
Change Today -38.00p
% Change -0.32 %
52 Week High 12,144.00
52 Week Low 9,501.00
Volume 1,636,659
Shares Issued 1,550.22m
Market Cap £185,840m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.68% below the market average91.68% below the market average91.68% below the market average91.68% below the market average91.68% below the market average
92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average
Price Trend
57.75% above the market average57.75% above the market average57.75% above the market average57.75% above the market average57.75% above the market average
82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average
Income
87.48% below the market average87.48% below the market average87.48% below the market average87.48% below the market average87.48% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average

What The Brokers Say

Strong Buy 8
Buy 13
Neutral 6
Sell 0
Strong Sell 1
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 26-Apr-2024

Time Volume / Share Price
16:36 400 @ 11,988.00p
16:36 600 @ 11,988.00p
16:36 53,995 @ 11,976.12p
16:35 680,675 @ 11,988.00p
16:35 2,636 @ 11,988.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page